Table 2 Sociodemographic, immunological and virological profile of chronically HIV-1 infected patients from Northwest Ethiopia
Variables | Male no. (%) | Female no. (%) | Total no. (%) |
|---|---|---|---|
| Â | 73 (45.4) | 87 (54.1) | 160 (100.0) |
Age (years) | Â | Â | Â |
<20 | 1 (1.4) | 2 (2.3) | 3 (1.9) |
20–29 | 19 (26.0) | 45 (51.7) | 64 (40.0) |
30–39 | 33 (45.2) | 24 (27.6) | 57 (35.6) |
40–49 | 15 (20.6) | 12 (13.8) | 27 (16.9) |
≥50 | 5 (6.8) | 4 (4.6) | 9 (5.6) |
WHO clinical status | Â | Â | Â |
I | 6 (8.2) | 13 (14.9) | 19 (11.9) |
II | 13 (17.8) | 15 (17.2) | 28 (17.5) |
III | 49 (67.1) | 57 (65.5) | 106 (66.3) |
IV | 5 (6.8) | 2 (2.3) | 7 (4.4) |
CD4+ T cell count (cells/mm3) | Â | Â | Â |
<100 | 26 (35.6) | 26 (29.9) | 52 (32.5) |
100–200 | 16 (21.9) | 31 (35.6) | 47 (29.4) |
201–350 | 29 (39.7) | 29 (33.3) | 58 (36.3) |
>350 | 2 (2.7) | 1 (1.1) | 3 (1.9) |
HIV RNA level (copies/ml) | Â | Â | Â |
103–104 | 13 (17.8) | 16 (18.4) | 29 (18.1) |
104–105 | 28 (38.4) | 38 (43.7) | 66 (41.3) |
105–106 | 29 (39.7) | 28 (32.2) | 57 (35.6) |
>106 | 3 (4.1) | 5 (5.7) | 8 (5.0) |